Results 21 to 30 of about 17,265 (194)

Preliminary outcomes of DEB-TACE loaded with raltitrexed in the treatment of unresectable or recurrent hepatocellular carcinoma

Cancer Imaging, 2023
Purpose Raltitrexed shows therapeutic effects and safety in many types of malignant tumors. However, reports of the clinical outcomes of raltitrexed-based transarterial chemoembolization (TACE) or drug-eluting beads TACE (DEB-TACE) in the treatment of ...
Yonghua Bi, Yang Wang, Wenguang Zhang, Huibin Lu, Jianzhuang Ren, Xinwei Han   +5 more
doaj   +1 more source

Transarterial chemoembolisation in patients with hepatocellular carcinoma: low-dose doxorubicin reduces post-embolisation syndrome without affecting survival—prospective interventional study

European Radiology Experimental, 2021
Background No chemotherapeutic agents have been standardised for transarterial chemoembolisation (TACE). In particular, doxorubicin has no defined optimal dosage in TACE procedures.
Ahmed A. Bessar, Ahmed Farag, Sameh M. Abdel Monem, Fady M. Wadea, Shady E. Shaker, Mahmoud Ahmed Ebada, Manar A. Bessar   +6 more
doaj   +1 more source

Balloon-occluded transarterial chemoembolization for hepatocellular carcinoma: History, background, and the roles

International Journal of Gastrointestinal Intervention, 2020
Super-selective lipiodol balloon-occluded transarterial chemoembolization (SSLB-TACE) increases lipiodol accumulation in the targeted nodule. To understand the mechanism of increased accumulation, it is necessary to understand intra-hepatic collateral ...
Toshiyuki Irie, Nobuyuki Takahashi, Sodai Hoshiai   +2 more
doaj   +1 more source

Gallbladder Perforation after Transarterial Chemoembolization in a Patient with a Huge Hepatocellular Carcinoma

The Korean Journal of Gastroenterology, 2020
Transarterial chemoembolization (TACE) is a common treatment for unresectable hepatocellular carcinoma (HCC). The most common complications after TACE are non-specific symptoms called post-embolization syndrome, such as abdominal pain or fever.
Min Young Son, Byung Hoon Han, Sang Uk Lee, Byung Cheol Yun, yung Cheol Yun, Jin Do Huh   +5 more
doaj   +1 more source

Reappraisal of Portal Vein Tumor Thrombosis as a Prognostic Factor for Patients with Hepatocellular Carcinoma

Gut and Liver
Background/Aims: This study aimed to assess whether hepatocellular carcinoma (HCC) patients with portal vein tumor thrombosis (PVTT) could have favorable prognoses with proper treatment under selective conditions.
Young Chang, Su Jong Yu, Hyo-Cheol Kim, Yun Bin Lee, Eun Ju Cho, Jeong-Hoon Lee, Yoon Jun Kim, Jin Wook Chung, Jung-Hwan Yoon   +8 more
doaj   +1 more source

Improved clinical outcome using transarterial chemoembolization combined with radiofrequency ablation for patients in Barcelona clinic liver cancer stage A or B hepatocellular carcinoma regardless of tumor size: results of a single-center retrospective case control study

BMC Cancer, 2019
Background To determine the safety and efficacy of transarterial chemoembolization (TACE) combined with radiofrequency ablation (hereafter, TACE-RFA) in treating Barcelona Clinic Liver Cancer (BCLC) Stage A or B (hereafter, BCLC A/B) hepatocellular ...
Yanqiao Ren, Yanyan Cao, Hong Ma, Xuefeng Kan, Chen Zhou, Jiacheng Liu, Qin Shi, Gansheng Feng, Bin Xiong, Chuansheng Zheng   +9 more
doaj   +1 more source

Rupture of hepatocellular carcinoma after transcatheter arterial chemoembolization: A case report

International Journal of Gastrointestinal Intervention, 2021
Transcatheter arterial chemoembolization (TACE) is one of the most common treatment options for patients with unresectable hepatocellular carcinoma (HCC). HCC rupture following TACE is a rare but potentially life-threatening complication.
Hye Hyeon Moon, Hee Ho Chu, Ji Hoon Shin
doaj   +1 more source

Spectral CT in evaluating the therapeutic effect of transarterial chemoembolization for hepatocellular carcinoma

Medicine, 2017
This study aimed to investigate the value of computed tomographic (CT) spectral imaging in evaluating the effect of transarterial chemoembolization (TACE).The records of 67 patients with hepatocellular carcinoma (HCC) who had undergone dynamic spectral CT before treatment were selected for the study.
Wang, Jun, Shen, Jia lin
openaire   +2 more sources

AMBULATORY MINI PERCUTANEOUS NEPHROLITHOTOMY (MINI-PCNL): FEASIBILITY AND OUTCOMES IN 1000 CASES IN PAKISTAN

Pakistan Armed Forces Medical Journal, 2020
Objective: To review the outcomes of a consecutive cohort of 1000 patients with renal stones managed with mini-percutaneous nephrolithotomy at our institute. Study Design: Prospective observational study.
Qamar Zia, Faran Kiani, Mudassar Sajjad, Muhammad Nawaz, Muhammad Akmal, Adil Khurshid, Asma Rizwan, Muzzammil Ali   +7 more
doaj  

Computed tomography perfusion in evaluating the therapeutic effect of transarterial chemoembolization for hepatocellular carcinoma

World Journal of Gastroenterology, 2008
To prospectively assess the changes in parameters of computed tomography (CT) perfusion pre- and post-transarterial chemoembolization (TACE) of hepatocellular carcinoma (HCC) in different treatment response groups, and to correlate the changes with various responses of HCC to TACE.Thirty-nine HCC patients underwent CT perfusion examinations pre-(1 d ...
Guang, Chen, Da-Qing, Ma, Wen, He, Bao-Feng, Zhang, Li-Qin, Zhao   +4 more
openaire   +2 more sources